Dyne Therapeutics, Inc. (DYN)
NASDAQ·Healthcare·Biotechnology
$18.19
+1.39%
Mkt Cap $2.97B
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (29 analysts)
$37.60
Range $23.00 – $60.00
Implied Upside
+106.7%
Consensus $37.60 vs current $18.19
NASDAQ·Healthcare·Biotechnology
$18.19
+1.39%
Mkt Cap $2.97B
Buy
6
Hold
1
Sell
0
Price Target (29 analysts)
$37.60
Range $23.00 – $60.00
+106.7%
Consensus $37.60 vs current $18.19